This article examines the mechanisms and potential targets of Nrf2 affecting endothelial cell dysfunction and delaying atherosclerosis, starting from the pathophysiological basis of CVDs to provide ideas for the development of new therapeutic methods for CVDs. The gene discussed is NFE2L2; the disease is atherosclerosis.